Pipamperone dihydrochloride
CAS : 2448-68-2
Ref. 3D-FF101592
1mg | Arrêté | ||
2mg | Arrêté | ||
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté |
Informations sur le produit
- 1-[4-(4-Fluorophenyl)-4-oxobutyl]-[1,4?-bipiperidine]-4?-carboxamide dihydrochloride
- (1,4'-Bipiperidine)-4'-carboxamide, 1'-(3-(p-fluorobenzoyl)propyl)-, dihydrochloride
- 4'-Carbamoyl-1'-[4-(4-Fluorophenyl)-4-Oxobutyl]-1,4'-Bipiperidinium Dichloride
- Nsc 170981
- Pipamperone HCl
- Pipamperone dichlorhydrate
- Pipamperone hydrochloride
- Piperonil
- Propitan
- [1,4′-Bipiperidine]-4′-carboxamide, 1′-[4-(4-fluorophenyl)-4-oxobutyl]-, dihydrochloride
- Voir d'autres synonymes
- [1,4′-Bipiperidine]-4′-carboxamide, 1′-[4-(4-fluorophenyl)-4-oxobutyl]-, hydrochloride (1:2)
Pipamperone is a 5-HT2 receptor antagonist that has been shown to be effective in the treatment of premenstrual syndrome. The drug lowers blood levels of estradiol benzoate, which is an active form of estrogen. Pipamperone also blocks the effects of dopamine on the 5-HT2 receptor, which can lead to extrapyramidal side effects. Pipamperone has been shown to be effective in the treatment of premenstrual syndrome and other symptoms related to mood disorders such as depression, anxiety, and irritability. The drug is usually administered orally at a dosage range of 50-300 mg/day for long-term efficacy. In order to determine the effectiveness of pipamperone in humans, it is necessary to measure its activity following administration with an analytical method that can detect its concentration in human serum or plasma. Pipamperone is a fluorescent probe that emits light when excited by ultraviolet light. A fluorescence probe can be used